BridgeBio Pharma, Inc. Q1 FY2024 Earnings Call

BridgeBio Pharma, Inc. (BBIO)

Earnings Call FY2024 Q1 Call date: 2024-05-29 Concluded

Quarter scorecard

Revenue

$211.12M

+11461.9% YoY

Diluted EPS

$-0.20

Net income

-$36.16M

License and Services Revenue $211.12M

Net Product Revenue $0